Ventyx Biosciences, Inc. Quarterly Debt-to-equity in % from Q2 2022 to Q2 2024

Taxonomy & unit: ratio: %
Description: Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary: Ventyx Biosciences, Inc. quarterly Debt-to-equity history and growth rate from Q2 2022 to Q2 2024.
Ventyx Biosciences, Inc. Debt-to-equity for the quarter ending June 30, 2024 was 11.2 %, a 73.8% increase year-over-year.

Debt-to-equity, Quarterly (%)

Debt-to-equity, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date
Q2 2024	11.2	+4.77	+73.8%	Jun 30, 2024
Q1 2024	10.1	+3.41	+50.7%	Mar 31, 2024
Q4 2023	8.99	+1.55	+20.8%	Dec 31, 2023
Q3 2023	7.04	-0.44	-5.89%	Sep 30, 2023
Q2 2023	6.47	-2.46	-27.6%	Jun 30, 2023
Q1 2023	6.73			Mar 31, 2023
Q4 2022	7.44			Dec 31, 2022
Q3 2022	7.47			Sep 30, 2022
Q2 2022	8.93			Jun 30, 2022

* An asterisk sign (*) next to the value indicates that the value is likely invalid.